TrialThorax2016

Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis.

Steven D Nathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.